Health Care

Price Target update of Most active stock: Arrowhead Research Corporation (NASDAQ:ARWR)

0 4

Arrowhead Research Corporation (NASDAQ:ARWR) dropped -0.84% and closed the trade at $ 7.08. The company recorded a trading capacity of 1.47 million shares above its three months average daily volume of 666.22 thousand shares. During the last trade, shares reached to high price of $7.27 and touched the low price of $7.02. The stock’s 50-day moving average is noted at $6.61 and its 200-day moving average is stands at $5.72.

Additionally, the companyhas EPS of -1.41. The company has market capitalization of $430.11M.

Currently Arrowhead Research Corporation (ARWR) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “4″ Analysts”. “0” rated “Sell” for the company. “2” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $9.42 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $15.00 however minimum price target advised by analysts is $5.50. The Median price target for the stock is measured at $9.00.

Presently, Analysts decided consensus EPS estimate of $-0.32 for present quarter and one month ago projected EPS estimate was at $-0.32. If we take a look at back 3 month ago, consensus EPS estimate was $-0.35.

A current consensus EPS estimate for next quarter is at $-0.34 and 3 month ago EPS forecast was $-0.45. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.34.

For current fiscal year, most recent EPS estimate is set at $-1.30 based on Analyst consensus and three month ago consensus EPS opinions was at $-1.40. During period one month ago, consensus EPS forecast was decided at $-1.32.

A current consensus EPS projection for next fiscal year is observed at $-1.33 and one month ago consensus EPS forecast was at $-1.39. Take a look at back three month ago, consensus EPS estimate opinions was decided at $-1.37 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 4 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 2 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 2 said a “Buy Rating” and 0 announced “Overweight Rating”. 2 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter